🇺🇸 FDA

Intelligence Platform

Patents

Browse 1,164 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 8227443

Silencing of CSN5 gene expression using interfering RNA

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Jul 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8227417

HMGN polypeptides as immune enhancers and HMGN antagonists as immune suppressants

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Jul 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8217158

Immunotoxin fusion proteins and means for expression thereof

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Jul 10 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 05 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8211422

Chimeric receptor genes and cells transformed therewith

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Jul 03 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 28 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8202551

Tissue engineered cartilage, method of making same, therapeutic and cosmetic surgical appl

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Jun 19 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 14 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8202520

Method of immunizing humans against Salmonella typhi using a Vi-rEPA conjugate vaccine

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Jun 19 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 14 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8198402

Smoothened polypeptides and methods of use

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Jun 12 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 07 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8188055

Inactivators of O6-alkylguanine-DNA alkyltransferase

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue May 29 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 24 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8178508

Methods of stimulating an immune response against prostate specific antigen

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue May 15 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 10 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8173123

Methods of treating colitis involving IL-13 and NK-T cells

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue May 08 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 03 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8153781

Dendrimer conjugates of agonists and antagonists of the GPCR superfamily

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Apr 10 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 05 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8147840

Human immunodeficiency virus (HIV) immunization strategies employing conformationally-stab

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Apr 03 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8125225

Transmit profile control in MRI

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Feb 28 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 23 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8110192

Human immunodeficiency virus type 1 (HIV-1)-neutralizing human single-chain antibodies wit

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Feb 07 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 02 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8110681

Compounds for the treatment of spinal muscular atrophy and other uses

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Feb 07 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 02 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8110352

Method of diagnosing and treating cancer using B-catenin splice variants

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Feb 07 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 02 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8093343

Nitric oxide-releasing diazeniumdiolated compounds

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Jan 10 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 05 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8088787

Methods related to the treatment of neurodegenerative and inflammatory conditions

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Jan 03 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 29 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8088729

Anti-viral griffithsin compounds, compositions and methods of use

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Jan 03 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 29 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8075900

Melanoma associated peptide analogues and vaccines against melanoma

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Dec 13 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 08 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8071746

Isolated nucleic acid molecule encoding a peptide or peptide analog comprising the SEQ ID

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Dec 06 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 01 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8048427

Subgenomic replicons of the flavivirus dengue

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Nov 01 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 27 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8044187

Human luteinizing hormone superagonists

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Oct 25 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 20 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8039003

Recombinant attenuated dengue viruses comprising a deletion in the 3′ untranslated region

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Oct 18 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 13 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted